Skip to main content

Advertisement

Log in

Endoscopic subureteral injection treatment with calcium hydroxylapatite in primary vesicoureteral reflux

  • Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Introduction

In this study, we aimed to evaluate efficiency of subureteral injection of calcium hydroxylapatite treatment for primary vesicoureteral reflux (VUR).

Materials and methods

A total of 25 children (mean age 6.9 ± 2.7 years) underwent subureteral injection of calcium hydroxylapatite for primary VUR. Reflux was present in 39 ureteral units that were unilateral in 11 cases and bilateral in 14 cases. According to “International Reflux Classification”; grade II in 12 (30.8%), grade III in 18 (46.2%) and grade IV in 9 (23.1%) ureteral units were found.

Results

The refluxes were resolved in 23 (59.0%) ureteral units after a single injection and 5 ureteral units (12.8%) after a second injection. Overall success rate of reflux treatment with calcium hydroxylapatite was 71.8% in all ureteral units.

Conclusion

Endoscopic subureteral injection of calcium hydroxylapatite in children with primary low-grade VUR appears to be an effective, safe and minimally invasive technique.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Atala A, Keating MA (2002) Vesicoureteral Reflux and Megaureter. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds). Campbell’s urology. Saunders Co., Philadelphia, 2053–2116

  2. Bailey RR, Maling TMJ, Swainson CP (1993) Vesicoureteral reflux and reflux nephropathy. In: Schrier RW, Gottschalk CW (eds). Diseases of the kidney. Little, Brown & Co., Boston 689–727

    Google Scholar 

  3. Abrams P, Mayer RD, Lawrence W, Hubbard WG (2002) Long-term clinical experience with Coaptite urological bulking agent. Eur Urol (S1): 618 (abstract)

  4. Mayer R, Lightfoot M, Jung I (2001) Preliminary evaluation of calcium hydroxylapatite as a transurethral bulking agent for stress urinary incontinence. Urology 57:434–438

    Google Scholar 

  5. Trsinar B, Cotic D, Oblak C (1999) Possible causes of unsuccessful endoscopic collagen treatment of vesicoureteric reflux in children. Eur Urol 36:635–639

    Google Scholar 

  6. Puri P, Chertin B, Velayudham M et al (2003) Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/hyaluronic acid copolymer: preliminary results. J Urol 170:1541–1544

    Article  PubMed  CAS  Google Scholar 

  7. Puri P (1995) Ten-year experience with subureteric Teflon (polytetraflouroethylene) injection (STING) in the treatment of vesicoureteral reflux. Br J Urol 75:126–131

    PubMed  CAS  Google Scholar 

  8. Merckx L, De Boe V, Braeckman J, et al (1995) Endoscopic submucosal Teflon injection (STING): an alternative treatment of vesicoureteral reflux in children. Eur J Pediatr Surg 5:34–36

    Article  PubMed  CAS  Google Scholar 

  9. Penco JMM, Fraile AG, Alarcon JR (2004) Evolution of the treatment of vesicoureteral reflux in Spain. J Urol 171:834–837

    Article  CAS  Google Scholar 

  10. Kershen RT, Atala A (1999) New advances in injectable therapies for the treatment of incontinence and vesicoureteral reflux. Urol Clin North Am 26:81–94

    Article  PubMed  CAS  Google Scholar 

  11. Haferkamp A, Contractor H, Mohring K, et al (2000) Failure of subureteral bovine collagen injection for the endoscopic treatment of primary vesicoureteral reflux in long-term follow-up. Urology 55:759–763

    Article  PubMed  CAS  Google Scholar 

  12. Leonard MP, Decter A, Hills K, et al (1998) Endoscopic subureteral collagen injection: are immunological concerns justified?. J Urol 160:1012–1016

    Article  PubMed  CAS  Google Scholar 

  13. Caldamone AA, Diamond DA (2001) Long-term results of the endoscopic correction of vesicoureteral reflux in children using autologous chondrocytes. J Urol 165:2224–2227

    Article  PubMed  CAS  Google Scholar 

  14. Al-Hunayan AA, Kehinde EO, Elsalam MA, et al (2002) Outcome of endoscopic treatment for vesicoureteral reflux in children using polydimethylsiloxane. J Urol 168:2181–2183

    Article  PubMed  CAS  Google Scholar 

  15. Oswald J, Riccabona M, Lusuardi L, et al (2002) Prospective comparison and one-year follow-up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Urology 60:894–897

    Article  PubMed  CAS  Google Scholar 

  16. Chertin B, Puri P (2002) Endoscopic management of vesicoureteral reflux: does it stand the test of time?. Eur Urol 42:598–606

    Article  PubMed  Google Scholar 

  17. Mevorach R, Rabinowitz R, Beck C et al. (2002) Endoscopic treatment of vesicoureteral reflux with Coaptite®: The first 50 patients. J Urol 167: 429 (abstract)

    Google Scholar 

  18. Puri P, Granata C (1998) Multicenter survey of endoscopic treatment of vesicoureteral reflux using polytetraflouroethylene. J Urol 160:1007–1011

    Article  PubMed  CAS  Google Scholar 

  19. Chertin B, De Caluwe D, Puri P (2003) Endoscopic treatment of primary grades IV and V vesicoureteral reflux in children with subureteral injection of polytetraflouroethylene. J Urol 169:1847–1849

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bilal Eryıldırım.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eryıldırım, B., Tarhan, F., Kuyumcuoğlu, U. et al. Endoscopic subureteral injection treatment with calcium hydroxylapatite in primary vesicoureteral reflux. Int Urol Nephrol 39, 417–420 (2007). https://doi.org/10.1007/s11255-006-9011-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-006-9011-y

Keywords

Navigation